BABUDIERI, Sergio
 Distribuzione geografica
Continente #
NA - Nord America 12.821
AS - Asia 7.809
EU - Europa 4.624
SA - Sud America 4.349
AF - Africa 303
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 21
AN - Antartide 1
Totale 29.954
Nazione #
US - Stati Uniti d'America 12.510
BR - Brasile 3.903
SG - Singapore 3.250
CN - Cina 2.205
UA - Ucraina 1.285
DE - Germania 755
HK - Hong Kong 738
IT - Italia 634
VN - Vietnam 556
FR - Francia 446
SE - Svezia 435
FI - Finlandia 304
GB - Regno Unito 250
AR - Argentina 140
IN - India 132
TR - Turchia 132
CA - Canada 129
BD - Bangladesh 121
MX - Messico 106
RU - Federazione Russa 103
IQ - Iraq 102
ZA - Sudafrica 88
EC - Ecuador 82
JP - Giappone 64
MA - Marocco 62
CZ - Repubblica Ceca 61
VE - Venezuela 60
UZ - Uzbekistan 56
PK - Pakistan 54
AE - Emirati Arabi Uniti 51
PL - Polonia 51
ES - Italia 47
CO - Colombia 44
NL - Olanda 42
BE - Belgio 40
PY - Paraguay 39
AT - Austria 37
KE - Kenya 37
ID - Indonesia 33
NP - Nepal 29
KR - Corea 27
TN - Tunisia 27
AZ - Azerbaigian 26
AU - Australia 25
JO - Giordania 24
UY - Uruguay 24
PE - Perù 23
RO - Romania 23
CL - Cile 22
LB - Libano 22
DZ - Algeria 21
PH - Filippine 20
SA - Arabia Saudita 20
DO - Repubblica Dominicana 19
IL - Israele 19
JM - Giamaica 18
KZ - Kazakistan 18
EG - Egitto 17
LT - Lituania 16
PS - Palestinian Territory 16
KG - Kirghizistan 15
IR - Iran 14
OM - Oman 14
BG - Bulgaria 12
RS - Serbia 12
AL - Albania 11
EU - Europa 10
HU - Ungheria 9
PA - Panama 9
SN - Senegal 9
BO - Bolivia 8
HN - Honduras 8
KW - Kuwait 8
CH - Svizzera 7
IE - Irlanda 7
MY - Malesia 7
XK - ???statistics.table.value.countryCode.XK??? 7
BY - Bielorussia 6
CR - Costa Rica 6
ET - Etiopia 6
MK - Macedonia 6
NG - Nigeria 6
AO - Angola 5
BN - Brunei Darussalam 5
NI - Nicaragua 5
QA - Qatar 5
AM - Armenia 4
GE - Georgia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GT - Guatemala 3
GY - Guiana 3
LU - Lussemburgo 3
LY - Libia 3
MD - Moldavia 3
TG - Togo 3
Totale 29.903
Città #
Dallas 4.077
Singapore 1.746
Chandler 1.432
San Jose 1.095
Jacksonville 737
Hong Kong 726
Ashburn 618
Princeton 467
Beijing 460
Nanjing 307
New York 304
Dearborn 286
São Paulo 268
Lauterbourg 242
Munich 193
Wilmington 191
Ho Chi Minh City 190
Los Angeles 173
Sassari 158
Shanghai 157
Hanoi 147
Boardman 146
Ann Arbor 130
Rio de Janeiro 129
Nanchang 126
Santa Clara 125
Helsinki 114
Belo Horizonte 102
Shenyang 101
Brasília 86
Woodbridge 81
Tianjin 76
Hebei 66
Changsha 60
Curitiba 58
Tokyo 58
Brno 56
Council Bluffs 56
Porto Alegre 54
Campinas 52
Rome 51
Columbus 49
Nuremberg 49
Guarulhos 48
Orem 48
Frankfurt am Main 46
Salvador 46
Tashkent 46
Warsaw 46
Johannesburg 45
Denver 44
Toronto 44
Montreal 42
San Francisco 42
Goiânia 41
The Dalles 40
Atlanta 39
Brussels 39
Jiaxing 39
Brooklyn 38
Buffalo 38
Cagliari 37
Chennai 37
Guangzhou 36
Ningbo 36
Zhengzhou 36
Jinan 35
Ribeirão Preto 34
Kunming 33
Nairobi 33
London 32
Andover 31
Chicago 31
Norwalk 31
Baghdad 30
Dhaka 30
Guayaquil 30
São José dos Campos 30
Fortaleza 29
Houston 27
Seoul 27
Sorocaba 27
Santo André 26
Stockholm 26
Istanbul 25
Ankara 24
Asunción 24
Baku 24
Hangzhou 24
Izmir 23
Poplar 23
Turku 23
Amman 22
Phoenix 22
Quito 22
Taizhou 22
Campo Grande 21
Da Nang 21
Florianópolis 21
Joinville 21
Totale 17.656
Nome #
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 279
Differences in HCV Seroprevalence, Clinical Features, and Treatment Outcomes between Female and Male Incarcerated Population: Results from a Matched Cohort Study 276
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 263
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 219
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 213
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 212
A case of vasculitis-like skin eruption associated with COVID-19 206
Anaerobic bacteria and bacterial infections: perspectives on treatment and resistence in Italy 203
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 201
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 197
Associazione tra Tubercolosi ed infezione da HIV: programma per uno studio multicentrico 196
Blood born viral infections, sexually transmitted diseases and latent tuberculosis in italian prisons: a preliminary report of a large multicenter study 190
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 190
Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area 188
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 183
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 182
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 175
Application of a miniaturized system to the study of the intestinal microflora 175
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 174
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 173
Beta2-microglobulin and Neopterin: predictive markers of AIDS in HIV infection 171
Evaluation of EZH2 expression in hepatitis B patients 171
An outbreak of Q fever in a prison in Italy 170
A young woman with hepatitis after a sore throat 169
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 166
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 166
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 166
A systematic review on models of care effectiveness and barriers to Hepatitis C treatment in prison settings in the EU/EEA 164
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 160
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 160
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 160
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 157
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 157
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 156
Dental care and HIV-infected individuals: are they equally treated? 156
Association of Tuberculosis risk with the degree of tubercolin reaction in HIV-infected patients 156
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 155
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 153
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 152
Mitochondrial toxicity and body shape changes during nucleos(t)ide analogues administration in patients with chronic hepatitis B 150
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis? 149
Natalizumab therapy modulates miR-155, miR-26a and proinflammatory cytokine expression in MS patients 149
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 144
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 142
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay 140
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 140
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 140
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 139
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 139
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 138
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 137
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 137
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 137
An Outbreak of Q fever in a prison in Italy 135
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 134
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 134
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 133
Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature 132
Tuberculosis Screening before Anti–Hepatitis C Virus Therapy in Prisons 131
Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy 131
Relazione tra antigenemia ed anticorpi nell'evoluzione dell'infezione da HIV 131
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 130
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 129
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 129
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 128
Vaccinations in prison settings: A systematic review to assess the situation in EU/EEA countries and in other high income countries 128
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 127
Produzione di linee cellulari ibride per l'isolamento di virus linfotropi 127
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 126
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 125
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 125
L'attività di Imipenem contro i microrganismi anaerobi: studio policentrico su ceppi isolati da infezioni umane e confronto in vitro con altri antibiotici 125
Clostridi elicoidali: nuovi patogeni intestinali? Comparazione tra un ceppo umano e ceppi di provenienza animale 124
Infectious diseases screening approach among refugees: Results from a single-center study 124
Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy 123
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 123
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 122
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 122
Feasibility and efficacy of eight weeks Glecaprevir/Pibrentasvir to treat incarcerated viremic HCV patients: a case-control study 122
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 122
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 121
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL) 121
Tache Noire in a Patient with Acute Q Fever 121
Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program 121
Enterococcal infections of the respiratory tract in HIV patients 120
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 120
Trasmissione eterosessuale dell'infezione da HIV1 nella provincia di Sassari 120
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 119
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 119
Good safety profile and efficacy of leucocyte interferon-alpha in combination with oral ribavirin in treatment-naive patients with chronic hepatitis C: a multicentre, randomised, controlled study 119
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 118
HIV related aneurisms 118
Eritema cronico migrante 118
Flora batterica intestinale ed organismo ospite; aspetti attuali di fisiopatologia 117
Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) 117
HNK1 perifereal blood lymphocytes in HIV infected patients 117
Diarrea associata a Clostridium spiroforme 116
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 116
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 115
Diarrhoea associated with toxigenic Clostridium spiroforme 115
Totale 14.951
Categoria #
all - tutte 124.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 0 43
2021/20221.113 170 14 7 13 10 15 41 79 89 62 134 479
2022/20232.754 278 161 68 455 299 447 23 321 466 29 113 94
2023/2024904 152 60 24 25 238 117 15 42 1 5 64 161
2024/20258.234 131 90 490 200 315 265 748 1.550 2.729 1.122 342 252
2025/202612.058 496 3.087 1.815 1.625 1.171 664 1.700 324 445 480 199 52
Totale 30.486